Pipeline - PTX Therapeutics

Toggle menu

HOME
ABOUT US
TECHNOLOGIES
- Our Technologies
- PIPELINE
INVESTORS
MEDIA
- Media
- Briefing recordings
  - Q&A Update with Professor H. Miles Prince
CONTACT US

Protected: Pipeline

Home > Protected: Pipeline

This content is password-protected. To view it, please enter the password below.

Password:

Prescient Therapeutics is a clinical stage oncology company developing targeted therapies to treat cancer.

CONTACT

P: +61 3 9692 7222

F: +61 3 9077 9233

E: admin@ptxtherapeutics.com

INVESTORS

This Investor Centre was built by Reach Markets.
Visit Reach Markets here

Subscribe for updates

What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets provides Corporate Advisory Services, including managing investor communications on behalf of Prescient Therapeutics Limited and may receive fees for its services.

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.

A gross income of $250,000 or more per annum in each of the previous two financial years; or
Net assets of at least $2.5 million; and
A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)